| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7041 |
| Human Intestinal Absorption | HIA+ | 0.9880 |
| Caco-2 Permeability | Caco2+ | 0.7477 |
| P-glycoprotein Substrate | Non-substrate | 0.5538 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9817 |
| Non-inhibitor | 0.9789 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7853 |
| Distribution |
| Subcellular localization | Lysosome | 0.3943 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7659 |
| CYP450 2D6 Substrate | Substrate | 0.7463 |
| CYP450 3A4 Substrate | Non-substrate | 0.6177 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6196 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9314 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.7747 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6798 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9440 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8930 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8874 |
| Non-inhibitor | 0.8748 |
| AMES Toxicity | Non AMES toxic | 0.8344 |
| Carcinogens | Non-carcinogens | 0.8540 |
| Fish Toxicity | High FHMT | 0.8481 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7041 |
| Honey Bee Toxicity | High HBT | 0.5703 |
| Biodegradation | Not ready biodegradable | 0.9268 |
| Acute Oral Toxicity | II | 0.5311 |
| Carcinogenicity (Three-class) | Non-required | 0.7517 |